📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence. (2022)

First Author: Romano A

Attributed to: Childhood hypertrophic cardiomyopathy: characterising early phenotypes and disease progression to identify novel therapeutic targets funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/ec-21-0549

PubMed Identifier: 34939937

Publication URI: http://europepmc.org/abstract/MED/34939937

Type: Journal Article/Review

Volume: 11

Parent Publication: Endocrine connections

Issue: 1

ISSN: 2049-3614